Financial Times: Sanofi to launch dengue mass vaccination program
“Sanofi will launch the world’s first mass vaccination program for dengue fever in the Philippines on Monday, bringing to fruition a 20-year development process in which the French pharmaceuticals group has invested €1.5bn [$1.7 billion]. One million Filipino schoolchildren are to be inoculated against the virus at a price of €20 [$23] a shot in a scheme that Sanofi hopes will be replicated across the swath of tropical and subtropical countries affected by the mosquito-borne disease…” (Ward, 4/4).